Heritage Wealth Advisors Organon & Co. Transaction History

Heritage Wealth Advisors

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Dec 12, 2024	BUY	$19.27 - $24.63 $115 - $147	6 New	6 $0
Q2 2023 Aug 09, 2023	BUY	$19.27 - $24.63 $115 - $147	6 New	6 $0
Q3 2022 Dec 12, 2024	BUY	$23.4 - $34.25 $3,252 - $4,760	139 New	139 $3,000
Q3 2022 Nov 10, 2022	SELL	$23.4 - $34.25 $280 - $411	-12 Reduced 7.95%	139 $3,000
Q2 2022 Aug 04, 2022	SELL	$31.66 - $38.9 $5,698 - $7,002	-180 Reduced 54.38%	151 $5,000
Q1 2022 May 11, 2022	SELL	$30.45 - $39.36 $12,027 - $15,547	-395 Reduced 54.41%	331 $12,000
Q4 2021 Feb 02, 2022	SELL	$28.67 - $37.13 $86 - $111	-3 Reduced 0.41%	726 $22,000
Q2 2021 Aug 09, 2021	BUY	$28.45 - $38.0 $20,740 - $27,702	729 New	729 $22,000

790

201M

1.71M

865K

Ticker OGN
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 254,330,000
Market Cap $4.17B
Description
Organon & Co., a health care company, develops and delivers health solutions through a portfolio of prescription therapies in the United States and internationally. Its women's health portfolio comprises contraception and fertility brands, such as Nexplanon/Implanon, a long-acting reversible contraceptive. The company's biosimilars portfolio...

Get notified when there are updates to the investment portfolio of Heritage Wealth Advisors, based on Form 13F filings with the SEC.

Stay updated on Heritage Wealth Advisors with notifications on news.